![]() |
| Joana B. Pereira, researcher at Lund University and Karolinska Institutet who is first author of the study. Photo Credit: Courtesy of Lund University |
Scientific Frontline: Extended "At a Glance" Summary: Microglia and TREM2 in Alzheimer's Disease
The Core Concept: Microglia are the primary immune cells of the central nervous system that, when activated in a specific manner, trigger protective inflammatory mechanisms to slow the progression of Alzheimer's disease.
Key Distinction/Mechanism: Contrary to the traditional view that brain inflammation is strictly harmful, the activation of the TREM2 receptor on microglial cells enables them to sense disintegrating cell debris and consume harmful tau proteins, thereby reducing toxic accumulation.
Major Frameworks/Components:
- Microglial Cells: The resident macrophages of the central nervous system responsible for clearing viruses, infectious agents, and damaged cells.
- TREM2 Protein: A surface receptor on microglia that triggers a protective immune response when activated, though specific mutations in this protein can increase disease risk.
- Tau Pathology: Thread-like protein structures whose accumulation in brain cells is a major hallmark of Alzheimer's disease; this accumulation is mitigated by microglial consumption.
- Protective Inflammation: A recontextualization of neurological inflammation as a potentially beneficial immune response when driven by specific receptor activation.
.jpg)
.jpg)


.jpg)

.jpg)

